Loading…
Carlsmed, Inc. is projected to rise to $12.37 by 2027, a +4% move from its current price of $11.90. CARL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $11.43 | $11.90 | $12.39 | 0.00% |
| Jul 14 | $11.24 | $11.90 | $12.60 | 0.00% |
| Jul 15 | $11.09 | $11.90 | $12.76 | 0.00% |
| Jul 16 | $10.98 | $11.90 | $12.90 | +0.01% |
| Jul 17 | $10.87 | $11.90 | $13.03 | +0.01% |
| Jul 18 | $10.78 | $11.90 | $13.14 | +0.01% |
| Jul 19 | $10.69 | $11.90 | $13.25 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.69 | $11.90 | $13.25 | +0.01% |
| Week 2 | $10.23 | $11.90 | $13.85 | +0.02% |
| Week 3 | $9.89 | $11.90 | $14.33 | +0.03% |
| Week 4 | $9.61 | $11.90 | $14.75 | +0.04% |
| Week 5 | $9.37 | $11.91 | $15.13 | +0.04% |
| Week 6 | $9.16 | $11.91 | $15.48 | +0.05% |
| Week 7 | $8.97 | $11.91 | $15.81 | +0.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Carlsmed, Inc. is a healthcare company that designs, manufactures, and markets AI-enabled personalized spine surgery solutions. It operates in the commercial-stage medical technology space and develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
The aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
Carlsmed, Inc. (CARL) is the asset in the healthcare sector, currently trading at $11.76. It holds a market capitalization of $319.69M and is ranked 3432 by market cap.
A major floor 26.8% below — a decisive break under it would weaken the trend.
The nearest floor, 17.3% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 19.0% above — clearing it would confirm fresh momentum.
Key CARL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CARL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.22 | Sell | $12.00 | Sell |
| MA 10 | $11.74 | Buy | $11.77 | Buy |
| MA 20 | $11.25 | Buy | $11.47 | Buy |
| MA 50 | $10.88 | Buy | $11.13 | Buy |
| MA 100 | $10.98 | Buy | $11.25 | Buy |
| MA 200 | $12.04 | Sell | $11.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.84 | Neutral |
| Stoch RSI (14) | 71.60 | Neutral |
| CCI (20) | 67.39 | Neutral |
| Williams %R (14) | -24.54 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 11.32 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 75.46 | Neutral |
| TRIX (15) | 0.27 | Buy |
| Awesome (5,34) | 0.92 | Buy |
| Ultimate (7,14,28) | 65.28 | Neutral |
| Momentum (10) | 0.66 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 12.41 | Sell |
| ADX (14) | 13.24 | Neutral |
| ATR (14) | 0.44 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The SMA50 is $10.62 and the SMA200 is $12.17, indicating a tug between near-term support and resistance. The stock trades within a 30-day range of $9.39 to $14.73, with a defined support at $9.84 and resistance at $12.65.
The implied volatility is high at 70%, reflecting notable price movement potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.83 | $11.90 | $14.98 | 0% | Neutral | |
| $8.95 | $12.37 | $18.49 | +4% | Neutral | |
| $7.96 | $11.70 | $18.65 | -2% | Neutral | |
| $8.16 | $12.65 | $21.18 | +6% | Neutral | |
| $9.62 | $15.65 | $27.28 | +31% | Bullish | |
| $10.39 | $17.67 | $31.90 | +49% | Bullish | |
| $11.93 | $21.19 | $39.46 | +78% | Bullish | |
| $11.38 | $21.07 | $40.33 | +77% | Bullish | |
| $9.63 | $18.56 | $36.43 | +56% | Bullish | |
| $10.66 | $21.39 | $42.96 | +80% | Bullish | |
| $14.84 | $32.98 | $72.86 | +177% | Bullish | |
| $26.61 | $59.13 | $136.01 | +397% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.83 | $11.90 | $14.26 | +0.00% |
| August 2026 | $9.67 | $11.72 | $14.80 | -1.50% |
| September 2026 | $9.69 | $11.91 | $15.36 | +1.64% |
| October 2026 | $9.13 | $11.37 | $14.92 | -4.56% |
| November 2026 | $8.63 | $10.85 | $14.45 | -4.56% |
| December 2026 | $8.74 | $11.10 | $14.98 | +2.29% |
Click any year to see its month-by-month CARL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CARL price prediction for 2026 points to an average of $11.90 (low $8.83, high $14.98) — a potential gain of 0% on today's $11.90. A consolidation phase looks the most probable path here.
In 2027, CARL is projected to trade between $8.95 and $18.49, averaging $12.37 — a potential gain of +4% from today's $11.90. That is up +4% on the projected 2026 average. Price action looks broadly range-bound.
Carlsmed, Inc.'s 2028 outlook centres on $11.70, within a $7.96 to $18.65 range. That is -5% versus the projected 2027 average. That marks a -2% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, CARL could reach as high as $21.18, with a base case around $12.65 and support toward $8.16 — roughly +6% from $11.90. Price action looks broadly range-bound.
Expect CARL to range from $9.62 to $27.28 through 2030. The $15.65 average target implies a +31% move from current prices. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CARL price prediction for 2031 points to an average of $17.67 (low $10.39, high $31.90) — a potential gain of +49% on today's $11.90. Momentum favours further upside here.
In 2032, CARL is projected to trade between $11.93 and $39.46, averaging $21.19 — a potential gain of +78% from today's $11.90. That is up +20% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Carlsmed, Inc.'s 2033 outlook centres on $21.07, within a $11.38 to $40.33 range. That is -1% versus the projected 2032 average. That marks a +77% change versus current levels. Momentum favours further upside here.
By 2034, CARL could reach as high as $36.43, with a base case around $18.56 and support toward $9.63 — roughly +56% from $11.90. Buyers look set to stay in control over this stretch.
Expect CARL to range from $10.66 to $42.96 through 2035. The $21.39 average target implies a +80% move from current prices. That is up +15% on the projected 2034 average. Momentum favours further upside here.
The CARL price prediction for 2040 points to an average of $32.98 (low $14.84, high $72.86) — a potential gain of +177% on today's $11.90. Buyers look set to stay in control over this stretch.
In 2050, CARL is projected to trade between $26.61 and $136.01, averaging $59.13 — a potential gain of +397% from today's $11.90. That is up +79% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CARL today (≈ 84.033613 CARL) could be worth
$4,969.17
+$3,969.17 (+397%) by 2050 · US Dollar
Based on the average projected CARL price of $59.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CARLwould be worth at today's price.
$1,000 invested in CARL on Jul 23, 2025 (≈ 68.965517 CARL) would be worth
$820.69
-$179.31 (-17.9%) today · 0.82× · US Dollar
Based on a CARL entry price of $14.5 vs. today's $11.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.34 | $1,049.38 | +4.9% |
| 1 month ago | $11.45 | $1,039.3 | +3.9% |
| 3 months ago | $8.94 | $1,331.1 | +33.1% |
| 6 months ago | $14.44 | $824.1 | -17.6% |
| All time ago | $14.5 | $820.69 | -17.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CARL forecast.
Our base-case forecast reaches $24.00 around 2040.
Implied market cap at $24.00: $652.44M
The multi-year forecast shows a bullish path starting 2030, with 2030 average price of $16.55 and a corresponding ROI of 40.7% (sentiment BULLISH). The trajectory continues with 2031 average $19.11 (ROI 62.5%), 2032 average $22.35 (ROI 90%), 2033 average $21.98 (ROI 86.9%), 2034 average $20.62 (ROI 75.3%), and 2035 average $23.95 (ROI 103.6%). By 2040, the average price is projected at $36.47 (ROI 210.1%), and by 2050 the average price reaches $68.60 (ROI 483.3%), with sentiment remaining BULLISH.
These are estimates and not guarantees and depend on market conditions and company performance.
Tap a question to reveal the answer.
Avg $16.55, min $10.75, max $27.54; ROI 40.7%; sentiment BULLISH.
The forecast shows a bullish long-term trajectory, with 2030 avg $16.55 and 2030 max $27.54, though 2026 shows avg $11.76 with neutral sentiment; these are estimates, not guarantees.
Yes. The 2031 max is $32.81 and the 2032 avg is $22.35 (2032 max $39.46), indicating it could exceed $20 in coming years.
By 2040 the avg price is $36.47 (ROI 210.1%), and by 2050 the avg price is $68.60 (ROI 483.3%), with bullish sentiment across the horizon.
Current price is $11.76 and market cap is $319.69M.
Carlsmed, Inc. Community Discussion
0Share your Carlsmed, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.